drug
(estradiol + progesterone)
Marketedupdated 3mo agoby $DARE Dare Bioscience, Inc.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(6)
approval · 6
Oct 28, 2018
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Jun 22, 2021
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Jun 22, 2021
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Dec 28, 2021
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Feb 15, 2024
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Feb 12, 2026
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 21, 2032
~6.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (39)
- Nov 21, 2032formulationUS 10052386
- Nov 21, 2032formulationUS 10052386
- Nov 21, 2032method-of-use (U-2439)US 10206932
- Nov 21, 2032method-of-use (U-2439)US 10206932
- Nov 21, 2032formulationUS 10639375
- Nov 21, 2032method-of-use (U-2439)US 10675288
- Nov 21, 2032method-of-use (U-2439)US 10675288
- Nov 21, 2032formulationUS 10806740
- Nov 21, 2032formulationUS 11033626
- Nov 21, 2032formulationUS 11033626
- Nov 21, 2032method-of-use (U-2439)US 11103513
- Nov 21, 2032formulationUS 11103516
- Nov 21, 2032formulationUS 11110099
- Nov 21, 2032formulationUS 11166963
- Nov 21, 2032formulationUS 11529360
- Nov 21, 2032method-of-use (U-2439)US 11793819
- Nov 21, 2032method-of-use (U-2439)US 11793819
- Nov 21, 2032compositionUS 11865179
- Nov 21, 2032compositionUS 11865179
- Nov 21, 2032formulationUS 8633178
- Nov 21, 2032formulationUS 8633178
- Nov 21, 2032method-of-use (U-2439)US 8846648
- Nov 21, 2032method-of-use (U-2439)US 8846648
- Nov 21, 2032formulationUS 8846649
- Nov 21, 2032formulationUS 8846649
- Nov 21, 2032formulationUS 8933059
- Nov 21, 2032formulationUS 8987237
- Nov 21, 2032formulationUS 8987237
- Nov 21, 2032formulationUS 8993548
- Nov 21, 2032formulationUS 8993548
- Nov 21, 2032formulationUS 8993549
- Nov 21, 2032formulationUS 8993549
- Nov 21, 2032formulationUS 9006222
- Nov 21, 2032method-of-use (U-2439)US 9114145
- Nov 21, 2032method-of-use (U-2439)US 9114145
- Nov 21, 2032formulationUS 9114146
- Nov 21, 2032formulationUS 9114146
- Nov 21, 2032formulationUS 9301920
- Nov 21, 2032formulationUS 9301920
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that